The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Open accessAbstract
Hypertension is common among patients with diabetes, with the prevalence depending on type and duration of diabetes, age, sex, race/ethnicity, BMI, history of glycemic control, and the presence of kidney disease, among other factors (1-3).Furthermore, hypertension is a strong risk factor for atherosclerotic cardiovascular disease (ASCVD), heart failure, and microvascular complications.ASCVDddefined as acute coronary syndrome, myocardial infarction (MI), angina, coronary or other arterial revascularization, stroke, transient ischemic attack, or peripheral arterial disease presumed to be of atherosclerotic origindis the leading cause of morbidity and mortality for individuals with diabetes and is the largest contributor to the direct and indirect costs of diabetes.Numerous studies have shown that antihypertensive therapy reduces ASCVD events, heart failure, and microvascular complications in people with diabetes (4-8).Large benefits are seen when multiple risk factors are addressed simultaneously (9).There is evidence that ASCVD morbidity and mortality have decreased for people with diabetes since 1990 (10,11) likely due in large part to improvements in blood pressure control (12-14).This Position Statement is intended to update the assessment and treatment of hypertension among people with diabetes, including advances in care since the American Diabetes Association (ADA) last published a Position Statement on this topic in 2003 (3). DEFINITIONS, SCREENING, AND DIAGNOSISRecommendations c Blood pressure should be measured at every routine clinical care visit.Patients found to have an elevated blood pressure ($140/90 mmHg) should have blood pressure confirmed using multiple readings, including measurements on a separate day, to diagnose hypertension.B c All hypertensive patients with diabetes should have home blood pressure monitored to identify white-coat hypertension.B c Orthostatic measurement of blood pressure should be performed during initial evaluation of hypertension and periodically at follow-up, or when symptoms of orthostatic hypotension are present, and regularly if orthostatic hypotension has been diagnosed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is strong evidence from clinical trials of the value of treating hypertension in older adults (70,71), with treatment of hypertension to individualized target levels indicated in most.”
From 13. Older Adults: Standards of Care in Diabetes—2024 (2024) · cites this paper as [71]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is strong evidence from clinical trials of the value of treating hypertension in older adults (72,73), with treatment of hypertension to individualized target levels indicated in most.”
From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is strong evidence from clinical trials of the value of treating hypertension in older adults”
From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Antihypertensive therapy reduces the risk of albuminuria (67)(68)(69)(70), and among people with type 1 or 2 diabetes with established CKD (eGFR <60 mL/min/1.73m 2 and UACR $300 mg/g creatinine), ACE inhibitor or ARB therapy reduces the risk of progression to ESKD (71)(72)(73)(74)(75)(76)(77)(78)(79)(80).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [70]
The cited source says what the claim attributes to it.
In the citing paper
“For individuals with albuminuria (urine albumin-to-creatinine ratio [UACR] $30 mg/g), initial treatment should include an ACE inhibitor or ARB to reduce the risk of progressive kidney disease (21) (Fig. 10.2).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [21]
In the citing paper
“For patients with albuminuria (urine albumin-to-creatinine ratio [UACR] $ 30 mg/g), initial treatment should include an ACE inhibitor or ARB to reduce the risk of progressive kidney disease (20) ( Fig. 10.2 ).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Research works printed but not linked: 1
- Lin JS, O’Connor EA, Evans CV, Senger CA, Rowland MG, Groom HC. Behavioral Counseling to Promote a Healthy Lifestyle for Cardiovascular Disease Prevention in Persons With Cardiovascular Risk Factors: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet], 2014. Rockville, MD, Agency for Healthcare Research and Quality (US), 2014. Available from http://www.ncbi.nlm.nih.gov/books/NBK241537/. Accessed 11 November 2016
Cited by
Sorted by citations
Items 501–600 of 714
Ramírez‐García, D., Perezalonso-Espinosa, J., Méndez-Labra, P. N., Fermín‐Martínez, C. A., Díaz-Sánchez, J. P., Paz‐Cabrera, C. D., Vargas‐Vázquez, A., López-Teros, M. T., Flood, D., Manne‐Goehler, J., et al. (2024) · medRxiv · doi:10.1101/2024.09.18.24313926 · Cited by 2
Mehdiyev, S. K., Мустафаев, И. И., & Мамедов, М. Н. (2019) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2019-3-48-56 · Cited by 1
yusefabad, H. H., kabi, R. S., Asadi, M., Hosseini, S. A., Abdi, M., Zakerkish, M., & Cheraghian, B. (2021) · Scientific Journal of Kurdistan University of Medical Sciences · doi:10.52547/sjku.26.3.25 · Cited by 1
Steroids and cardiovascular and metabolic disorders
Kumar, R., & McEwan, I. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91141-2.00003-9 · Cited by 1
A Review on Thiazole derivatives and their impact as hypoglycemic agents in drug developments
Rajesh, G. D., Kumar, P., Kumar, A., Kumbar, S. A., Murugeshwari, V., & Dixit, S. R. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00986 · Cited by 1
Drug-Drug Interactions and Their Association With Quality of Life in Patients With Hypertension
Gürel, N., Üresin, Y., & Şen, S. (2024) · Cureus · doi:10.7759/cureus.56526 · Cited by 1
Comparison between Ketogenic and Diabetic Conventional Diet on Wound Closure in Diabetic Rat Model
Saputra, M. D., Herman, H., & Whitiana, G. D. (2024) · Journal of Wound Management and Research · doi:10.22467/jwmr.2023.02418 · Cited by 1
Turki, F., Turki, I., Jdidi, J., & Said, H. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002628 · Cited by 1
Jiang, C., Liu, Y.-K., Cheng, P.-P., Dong, Y., Wang, X., Wu, F., Xia, Y., Wang, P., & Xu, X.-Y. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i4.102751 · Cited by 1
Ahmed, M., Altoyan, M., Hijazi, R., Aljebreen, J. A., Alshalan, M. H., Aldhalaan, R., & Altarifi, L. (2025) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1529_24 · Cited by 1
Vidhiastutik, Y., Indasah, I., & Widyowati, A. (2025) · Nurse and Holistic Care · doi:10.33086/nhc.v5i1.7171 · Cited by 1
Lu, Y., Teng, J., Huang, S., Dong, M., Qian, Y., Hu, Y., Yang, H., Zhou, Q., Meng, D., Ji, Y., et al. (2025) · Physiotherapy Research International · doi:10.1002/pri.70089 · Cited by 1
Khan, A. U., Sharif, M. J. H., Ashfaq, M., Khan, Q., Iqbal, M. M., Iqbal, A., Bashatah, A., Syed, W., & Alqahtani, N. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01041-8 · Cited by 3
Joshi, M., Pickard, A. S., Kim, K., Sharp, L. K., Gerber, B. S., & Touchette, D. R. (2025) · Quality of Life Research · doi:10.1007/s11136-025-04070-2 · Cited by 1
Bompoint, S., Billot, L., Patel, A. A., Woodward, M., Harris, K., Harrap, S. B., Mancia, G., Poulter, N. R., & Chalmers, J. P. (2026) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvag026 · Cited by 1
Personalised blood pressure ranges in type 2 diabetes?
Rutter, M. K., & Sattar, N. A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30002-0 · Cited by 1
Hypertension and Type 2 Diabetes Mellitus in Children and Adolescents
Baskaran, C., & Levitsky, L. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55138-0.00006-1 · Cited by 3
Singh, A., Dubey, R., Upmanyu, N., & Porwal, P. K. (2021) · Analytical Chemistry Letters · doi:10.1080/22297928.2021.1915865 · Cited by 1
Swain, P., & Banerjee, D. (2021) · Journal of Preventive Medicine and Holistic Health · doi:10.18231/j.jpmhh.2021.023 · Cited by 1
Geneti c Traits of Brachiocephalic Atherosclerosis
Nurimanshin, A. F., Bogdanov, R. R., Миронов, П. И., & Khusaenova, A. A. (2021) · Creative Surgery and Oncology · doi:10.24060/2076-3093-2021-11-4-293-299 · Cited by 1
Internal Medicine Resident Adherence to Evidence-Based Practices in Management of Diabetes Mellitus
Mehta, C., Cohen, D., Jaisinghani, P., & Parikh, P. D. (2022) · Journal of Medical Education and Curricular Development · doi:10.1177/23821205221076659 · Cited by 1
Majewski, C., & Bakris, G. L. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_5-2 · Cited by 1
Self-citationA Detroit Student-Run Free Clinic’s Management of Select Chronic Diseases
Beydoun, S. B., Lee, A. H., Durudogan, L., Kaufman, V., Potter, M., Askar, F., Tsouvalas, C. P., Reed, B., & Sherwin, R. L. (2022) · Cureus · doi:10.7759/cureus.26701 · Cited by 1
Risk Factors for Arterial Hypertension (Literature Review)
Брикс, К. В. (2022) · Medical Radiology and radiation safety · doi:10.33266/1024-6177-2022-67-4-24-35 · Cited by 1
Blood Pressure Thresholds for Initiation of Drug Treatment: Blood Pressure Targets in Diabetes
Dhaybi, O. A., & Bakris, G. L. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_23 · Cited by 1
Self-citationDiabetische Nierenerkrankung (Update 2023)
Sourij, H., Edlinger, R., Prischl, F. C., Kaser, S., Horn, S., Antlanger, M., Paulweber, B., Aberer, F., Brix, J. M., Cejka, D., et al. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-022-02147-3 · Cited by 1
Abhyankar, K. S., Solanki, K., & Patel, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15457-7.00011-3 · Cited by 1
Yaneva‐Sirakova, T., Zlatancheva, G., Karamfiloff, K. K., Traykov, L. D., Petrov, I. S., & Vassilev, D. I. (2023) · Folia Medica · doi:10.3897/folmed.65.e100100 · Cited by 1
Antihypertensive effect of Dapagliflozin in Type II diabetic patients with Hypertension
Hammoud, S., Boubou, A., & Kaddar, N. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00128 · Cited by 1
Ndagijimana, E., Nshimiyimana, A., Habyarimana, T., Izere, C., & Niyonzima, F. N. (2024) · East Africa Science · doi:10.24248/easci.v6i1.96 · Cited by 1
Clinical profile and risk factors for type-2 diabetes – A cross-sectional study
Okoro, P. N., Olarinoye, J. K., & Esan, A. (2024) · South Asian Journal of Health Sciences · doi:10.25259/sajhs_2_2023 · Cited by 1
Effects of Type II Diabetes on upper extremity muscle characteristics in older adults
Cox, L. G., Dias, N., Zhang, C., Zhang, Y., & Gorniak, S. L. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.138039 · Cited by 2
Ramezani, P., Amiri, M., Bagheri, A., & Naderi, F. (2024) · Jundishapur Journal of Health Sciences · doi:10.5812/jjhs-157051 · Cited by 1
Dhingra, R., He, F., Saunders, E. F. H., Waschbusch, D. A., Bixler, E. O., Greaney, J. L., Swigart, A. R., Al‐Shaar, L., Chinchilli, V. M., Yanosky, J. D., et al. (2025) · Psychiatry Research Communications · doi:10.1016/j.psycom.2025.100208 · Cited by 1
Sujon, H., Rahman, M. M., Haque, M. A., Banu, S., Ananta, T. T., & Sarker, M. H. R. (2025) · Cureus · doi:10.7759/cureus.87090 · Cited by 2
Стаценко, М. Е., Туркина, С. В., & Титаренко, М. Н. (2018) · Kardiologiia · doi:10.18087/cardio.2018.5.10118 · Cited by 1
Hypertension in Diabetic Kidney Disease
Ruiz‐Hurtado, G., & Ruilope, L. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-93521-8_20 · Cited by 1
Blutdruckziele bei Patienten mit Diabetes mellitus
Dederer, J., Bewarder, Y., Mahfoud, F., & Böhm, M. (2019) · Herz · doi:10.1007/s00059-019-4796-5 · Cited by 1
Mazur-Mucha, M., & Chrostowska, M. (2019) · Choroby Serca i Naczyń · doi:10.5603/chsin.2019.0035 · Cited by 1
Azab, A. E., Albasha, M. O., & Mansour, A. M. (2020) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2020.07.00195 · Cited by 1
AVALIAÇÃO DO PERFIL FARMACOTERAPÊUTICO DE GRUPO HIPERDIA EM UNIDADE DE SAÚDE DA FAMÍLIA
Braga, C. F., de Melo, T. P. G., & de Lima, J. G. (2020) · Infarma - Ciências Farmacêuticas · doi:10.14450/2318-9312.v32.e2.a2020.pp144-152 · Cited by 1
Inflammatory Mechanisms in Diabetic Kidney Disease
Alicic, R. Z., Cox, E. J., Neumiller, J. J., & Tuttle, K. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_32 · Cited by 1
HYPOGLYCEMIC EFFECT OF FLAXSEED LIGNAN AND B GLUCAN IN POSTMENOPAUSAL DIABETIC PATIENTS
Javed, F., & Abbas2, M. K. S. 1. A. N. (2021) · Agrobiological Records · doi:10.47278/journal.abr/2020.031 · Cited by 1
Virginia, D. M., Wahyuningsih, M. S. H., & Nugrahaningsih, D. A. A. (2021) · Asian Biomedicine · doi:10.2478/abm-2021-0021 · Cited by 1
Metabolic syndrome and kidney disease
Kramer, H., & Joshi, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00028-8 · Cited by 1
Zarkasi, K. A., Ramli, N. Z., Gopal, V., Shimmi, S. C., Miranda, A. L., Saudi, W. S. W., & Sunggip, C. (2020) · Borneo Journal of Medical Sciences (BJMS) · doi:10.51200/bjms.vi.2091 · Cited by 1
Arora, V., & Darshan, A. (2022) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/8206464 · Cited by 1
Alharbi, S. A., Nagarajrao, R., & Alharbi, A. H. (2019) · Journal of Liaquat University of Medical & Health Sciences · doi:10.22442/jlumhs.191810598 · Cited by 1
Diabetes and Hypertension: What Is the Connection?
Aswin., M., & Mohan, V. (2022) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-95734-6_12 · Cited by 1
Diabetic Nephropathy in Type 1 Diabetes Mellitus
Rossing, P. R. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_15 · Cited by 1
Self-citationFarag, H. A. M. (2022) · Kurdistan Journal of Applied Research · doi:10.24017/science.2022.1.11 · Cited by 1
Hypertension in Children with Type 2 Diabetes or the Metabolic Syndrome
Kim, G. E., & Flynn, J. T. (2023) · Springer eBooks · doi:10.1007/978-3-031-06231-5_19 · Cited by 1
Recent published hypertension guidelines: A critical approach
Manolis, A. J., & Kallistratos, M. S. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.04.005 · Cited by 1
Achila, O. O., Ghebretinsae, M., Kidane, A., Simon, M., Makonen, S., Rezene, Y., GaroyYohaness, E., Mebrahtu, G., & Ibrahim, O. A. (2021) · Research Square · doi:10.21203/rs.3.rs-139642/v1 · Cited by 1
dynaPhenoM: Dynamic Phenotype Modeling from Longitudinal Patient Records Using Machine LearningPreprint
Zhang, H., Zang, C., Xu, J., Zhang, H., Fouladvand, S., Havaldar, S., Su, C., Cheng, F., Glicksberg, B. S., Chen, J., et al. (2021) · medRxiv · doi:10.1101/2021.11.01.21265725 · Cited by 1
Occupational Noise Exposure and Diabetes Mellitus: A 3-year Retrospective Multicenter Cohort StudyPreprint
Yun, B., Sim, J., Kim, C.-Y., Lee, S., Oh, Y. S., Kim, S., Cho, A., Oh, J., Lee, J., & Yoon, J. (2021) · Research Square · doi:10.21203/rs.3.rs-959894/v1 · Cited by 1
Dey, S., Mukherjee, A., Pati, M. K., Kar, A., Ramanaik, S., Pujar, A., Malve, V., Mohan, H. L., Jayanna, K., & Swaroop, N. (2022) · Research Square · doi:10.21203/rs.3.rs-1618313/v1 · Cited by 1
From hypertension to heart failure
Manolis, A. J., & Lopatin, Y. M. (2023) · doi:10.1093/med/9780198891628.003.0004 · Cited by 1
Majewski, C., & Bakris, G. L. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_5-1
Self-citationPresence of Diabetes Does Not Mandate Lower Blood Pressure to Reduce Cardiovascular Events
Bakris, G. L., & Polonsky, T. S. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.016
Self-citationBeyond the new blood pressure guidelines: the beat goes on
López‐Candales, A. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1526624
HTA et diabète : quelle prise en charge en 2018 ?
Bouhanick, B. (2018) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2018.09.015
Management of Hypertension in Diabetes Mellitus
Doumas, M. N., & Bakris, G. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-92946-0_7
Self-citationConsideraciones en torno a las Guías USA 2017 de hipertensión arterial
Eduardo Fasce, H., Zárate, L. H., & Ortiz, L. (2018) · Revista médica de Chile · doi:10.4067/s0034-98872018001101317
Gorb, Y. G., Strona, V. I., & Komir, I. (2019) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs04.01.008
VASCULAR REMODELING IN HYPERTENSIVE PATIENTS WITH DIABETES AND OBESITY
Шелест, Б. О. (2019) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2019-1-2-149-197-200
INTERLEUKIN LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS
Шелест, Б. О. (2019) · Inter Collegas · doi:10.35339/ic.6.1.38-42
Acute, chronic, recovery, and prevention stages
Al-Shura, A. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817580-4.00004-4
Zhuravlyova, L., & Кулікова, М. В. (2019) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2019-34-3-33-39
Ahmed, A. S. (2019) · Assiut Scientific Nursing Journal · doi:10.21608/asnj.2019.58127
Ombada, M., & Ombada, M. (2019) · Global Journal of Health Science · doi:10.5539/gjhs.v12n1p106
Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
Fakheri, R. J., Bangalore, S., & Messerli, F. H. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87c.01001
Self-citationLifestyle-Related Diseases and Disorders
Chakrabarty, K., & Chakrabarty, A. S. (2019) · Springer eBooks · doi:10.1007/978-981-15-0962-9_11
Diabetes and cardiovascular risk
Karásek, D. (2018) · Interní medicína pro praxi · doi:10.36290/int.2018.011
Folami, R. O., Wennie, J., & Folami, E. O. (2020) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20202908
Nzesseu, V. L., Kouam, C. K., Tamokou, J.-D.-D., & Kuiate, J. (2020) · World Journal of Cardiovascular Surgery · doi:10.4236/wjcs.2020.109020
Ricci, M., Mancebo-Sevilla, J. J., García, J. G., García, M. G., & Huelgas, R. G. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.09.017
Akalu, Y., Yeshaw, Y., Tesema, G. A., Tiruneh, S. A., Teshale, A. B., Angaw, D. A., Gebrie, M., & Dagnew, B. (2020) · Research Square · doi:10.21203/rs.3.rs-121901/v1
Tactics to prevent or slow progression of CKD in patients with diabetes
Ahmad (2021) · The Journal of Family Practice · doi:10.12788/jfp.0126
Seasonal Changes in Incidence of Patients With Diabetes Undergoing Cardiac SurgeryPreprint
Kovács, B. N., Peták, F., Agócs, S., Virág, K., Nyári, T., Molnár, A., Südy, R., Lengyel, C., & Babik, B. (2020) · doi:10.21203/rs.3.rs-36836/v1
Liu, D., Zhang, J., Zhang, X., Tian, Q., Meng, X., Wu, L., Song, M., Hou, H., Wang, W., Meng, Q., et al. (2020) · doi:10.21203/rs.3.rs-38821/v1
RECONCILIAÇÃO MEDICAMENTOSA: ESTRATÉGIAS PARA A SEGURANÇA DO PACIENTE COM DIABETES E HIPERTENSÃO
da Silva, M. G., de Araújo, Y. B., Carneiro, F. B., & Pereira, M. D. S. V. (2021) · Temas em Saúde · doi:10.29327/213319.21.3-9
Kiburg, K., MacIsaac, A. I., McCluskey, G. E., Sundararajan, V., & MacIsaac, R. J. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02265-2
Blood pressure variability in diabetic patients with or without albuminuria
Davoudi, Z., Mashhadi, M. S., Mokhtari, N., & Sheibani, M. (2020) · Journal of Nephropathology · doi:10.34172/jnp.2022.06
Implementation of Battlefield Advanced Trauma Life Support (BATLS) in the Danish Armed Forces
Jensen, C. T., Johansson, A., Emmertsen, N.-C., de Mello, W., & Lundberg, L. E. R. (2013) · Borås Academic Digital Archive (University of Borås)
Drug Metabolism/Transport and Pharmacokinetics
Song, I.-S. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-2458-0
Majewski, C., & Bakris, G. L. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_5
Self-citationThe current state of diabetes treatment
Danquah, M. K., & Jeevanandam, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85396-5.00007-5
Бiловол, О. М., Knyazkova, І. І., Kіrienko, O. M., Kuzmіnova, N. V., Kіrienko, D. О., Bogun, M. V., & Havryliuk, A. O. (2022) · World of Medicine and Biology · doi:10.26724/2079-8334-2022-1-79-25-28
Self Organizing Maps for Diabetes Parameter AnalysisPreprint
Alexandru, D. (2019) · doi:10.31219/osf.io/eajms
Collier, A., Hair, M. D., Cameron, L., Ghosh, S., Boyle, J. G., Walters, M., & Waugh, N. (2021) · Journal of Epidemiology and Public Health Reviews · doi:10.16966/2471-8211.209
Shrestha, A., Suwal, R., Shrestha, R. K., & Khadka, D. (2022) · Nepalese Journal of Ophthalmology · doi:10.3126/nepjoph.v14i1.39723
Hypertension in Children with Type 2 Diabetes or the Metabolic Syndrome
Kim, G. E., & Flynn, J. T. (2022) · Springer eBooks · doi:10.1007/978-3-319-31420-4_19-2
Adzika, V. A., Appiah‐Poku, J., Mensah, D. K., Pedro, A., Ahorlu, C., Kantanka, S., & Quasie, O. (2022) · Research Square · doi:10.21203/rs.3.rs-1400729/v1
Elnaem, M. H., Kamarudin, N. H., & Mosaad, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1353498/v1
Metadata
- Authors
- de Boer, I. H., Bangalore, S., Benetos, A., Davis, A. M., Michos, E. D., Muntner, P., Rossing, P., Zoungas, S., & Bakris, G.
- Affiliations
- University of Washington, Seattle, WA
- New York University (US)
- Université de Lorraine, Nancy, France
- University of Chicago (US)
- Johns Hopkins University (US)
- University of Alabama at Birmingham (US)
- University of Copenhagen (DK)
- Monash University (AU)
- Corresponding author
- Bakris, George
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-08-14
- Volume
- 40
- Issue
- 9
- Pages
- 1273-1284
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2748201042
- Semantic Scholar
- 4e3c7fd3bbe3119a559b61514192347b33e3e619
- Cited by
- 714
- References
- 145
- Citations by year
- 2026: 30 · 2025: 67 · 2024: 89 · 2023: 69 · 2022: 102 · 2021: 113 · 2020: 83 · 2019: 81 · 2018: 71 · 2017: 5
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Ironwood Pharmaceuticals, Incorporated
- Medicines Company
- Steno Diabetes Center Copenhagen (SDCC 3.A Complications)
- Novo Nordisk
- Astellas Pharma
- Novo Nordisk Fonden (NNF14OC0013659)
- Servier
- Sanofi Australia
- Abbott Vascular
- Defense Acquisition Program Administration
- Relypsa
- National Heart, Lung, and Blood Institute
- Cilag
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- hypertension, diabetes mellitus, atherosclerotic cardiovascular disease, heart failure, microvascular complications, antihypertensive therapy, blood pressure screening, home blood pressure monitoring, white coat hypertension, orthostatic hypotension, blood pressure control, risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
